Authors
Loading...
Therapeutic cancer vaccines improve immunogenicity and safety in precision oncology, indicating a need for better validation and cost-effectiveness.
Tasselli et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: